Omeros Corp (OMER)

$2.61 0.03 (1.14%)

16:00 EDT OMER Stock Quote Delayed 30 Minutes

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Oct 18, 2021

Welcome back, trader! I hope the weekend served you well because we've got pre-market stock movers to start off Monday with!

OMER Stock: Why Little-Known Omeros Is Absolutely Plunging Today

Best ETFs for 2018: Don’t Sweat This Quarter for the SBIO ETF

Omeros’ (OMER) Robust Sales Growth Make it a Buy at recent price of $11.24

Volume:

Previous Close -

Market Cap 163.73M

PE Ratio 0.83

EPS 3.16

Volume (Avg. Vol.) 6.82M

Day's Range $2.61 - $2.85

52-Week Range $1.86 - $16.57

Dividend & Yield N/A (N/A)

OMER Stock Predictions, Articles, and Omeros Corp News

From InvestorPlace
From the Web

11 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Dec 9, 2016

The overall ratings of 11 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

7 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Oct 14, 2016

This week, 7 Pharmaceuticals stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

19 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Sep 2, 2016

This week, the overall grades of 19 Pharmaceuticals stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

16 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Aug 26, 2016

This week, the overall grades of 16 Pharmaceuticals stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

10 Pharmaceuticals Stocks to Buy Now

By Portfolio Grader Aug 19, 2016

The grades of 10 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

12 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader May 20, 2016

This week, 12 Pharmaceuticals stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").